The preferred treatment for stage I seminoma: a survey of Canadian radiation oncologists.
OBJECTIVE
To evaluate the preferences of radiation oncologists for managing stage I seminoma.


METHODS
An electronic survey evaluating the management of stage I seminoma patients was sent to Canadian radiation oncologists to determine their treatment recommendations and preferences.


RESULTS
The survey completion rate was 74% among eligible respondents (78/105). Most (56%) felt that surveillance was the preferred treatment for patients, whereas 31% thought that adjuvant radiotherapy was best, 1% chose adjuvant chemotherapy as being the preferred option and 12% were unsure. Most would choose the same treatment for themselves if they were diagnosed with stage I seminoma. A previously published survey found that most respondents considered radiotherapy as the best option.


CONCLUSIONS
Most Canadian radiation oncologists now favour surveillance for most stage I seminoma patients.
Alomary
I
I
Radiation Oncology Department, Ottawa Hospital Regional Cancer Centre, Ottawa, Ontario, Canada. ialomary@ottawahospital.on.ca
Samant
R
R
Genest
P
P
Eapen
L
L
Gallant
V
V
D002170:Canada; D017024:Chemotherapy, Adjuvant / Q000706:statistics & numerical data; D019538:Health Care Surveys; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D009919:Orchiectomy / Q000706:statistics & numerical data; D018787:Radiation Oncology / Q000706:statistics & numerical data*; D018714:Radiotherapy, Adjuvant / Q000706:statistics & numerical data; D018239:Seminoma / Q000473:pathology / Q000628:therapy*; D011795:Surveys and Questionnaires; D013736:Testicular Neoplasms / Q000473:pathology / Q000628:therapy*